惊蛰时分听春雷
Lv6
2750 积分
2022-08-01 加入
-
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
26天前
已完结
-
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study
2个月前
已完结
-
Pediatric Osteochondritis Dissecans of the Talus
2个月前
已关闭
-
Pediatric Osteochondritis Dissecans of the Talus
3个月前
已关闭
-
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial
3个月前
已完结
-
[Expert opinions on clinical application of interferon-γ release assay of Mycobacterium tuberculosis (2021 edition)]
3个月前
已完结
-
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
4个月前
已完结
-
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
4个月前
已完结
-
Palindromic rheumatism: Part of or apart from the spectrum of rheumatoid arthritis
5个月前
已完结
-
2021 ACR guideline for JIA reflects changes in practice
5个月前
已完结